What does Apotheek Ellen Cogge do?

Apotheek Ellen Cogge is a pharmacy in Gent. Private Limited, started on 28 March 2007, 1 establishment.

What is the address of Apotheek Ellen Cogge?

The registered office of Apotheek Ellen Cogge is located at Heerweg-Zuid 135, 9052 Gent.

Is Apotheek Ellen Cogge still active?

Yes. According to the CBE (31 October 2026) Apotheek Ellen Cogge is active, legal situation “Normale toestand”, started on 28 March 2007.

Is Apotheek Ellen Cogge registered on Peppol?

Yes, Apotheek Ellen Cogge is registered on the Peppol network with ID 0208:0888332136.

What is the enterprise number of Apotheek Ellen Cogge?

The enterprise number of Apotheek Ellen Cogge is BE0888332136.

When was Apotheek Ellen Cogge founded?

Apotheek Ellen Cogge was founded on 28 March 2007.

Who are the directors of Apotheek Ellen Cogge?

According to the 2025 annual accounts, the directors of Apotheek Ellen Cogge are: Copharelle BV.

Is Apotheek Ellen Cogge a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 March 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Ellen Cogge make in 2025?

Apotheek Ellen Cogge posted a profit after taxes of € 24,889 in financial year 2025.

What is the revenue of Apotheek Ellen Cogge?

As a small company, Apotheek Ellen Cogge is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 76,828.

How many employees does Apotheek Ellen Cogge have?

According to the 2025 annual accounts, Apotheek Ellen Cogge has 0.3 full-time equivalents (FTE).

Apotheek Ellen Cogge (Private Limited) - Gent

Dossier Apotheek Ellen Cogge, printed on 1 November 2026 from databakkes.be/en/0888332136/apotheek-ellen-cogge. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Ellen Cogge from Gent, company number BE0888332136, closed financial year 2025 with a result of € 24,889 after tax. For that financial year Apotheek Ellen Cogge recorded a gross margin of € 76,828 and equity of € 347,526. Compared with financial year 2024, the result moved from € 43,106 to € 24,889. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 347,526

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 24,889

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 185,371

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 24,889 paid out

100 % of the profit went to the shareholders, mostly to Copharelle (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.3

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 13,383

▲ € 10,860 vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,496

▼ 33% vs 2024

Of which on lease € 3,496.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3,674

▼ 79% vs 2024

€ 1,862 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 84,836

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 4,518

▲ € 3,416 vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 110,677 Gross margin 2022: € 110,677 First fiscal year in the series	€ 92,483 Gross margin 2023: € 92,483 ▼ 16% vs 2022 (€ 110,677) Unfavourable step	€ 90,598 Gross margin 2024: € 90,598 ▼ 2% vs 2023 (€ 92,483) Unfavourable step	€ 76,828 Gross margin 2025: € 76,828 ▼ 15% vs 2024 (€ 90,598) Unfavourable step	▼ 15%
Profit after taxes	€ 60,925 Profit after taxes 2022: € 60,925 First fiscal year in the series	€ 44,329 Profit after taxes 2023: € 44,329 ▼ 27% vs 2022 (€ 60,925) Unfavourable step	€ 43,106 Profit after taxes 2024: € 43,106 ▼ 3% vs 2023 (€ 44,329) Unfavourable step	€ 24,889 Profit after taxes 2025: € 24,889 ▼ 42% vs 2024 (€ 43,106) Unfavourable step	▼ 42%
Equity	€ 285,090 Equity 2022: € 285,090 First fiscal year in the series	€ 304,419 Equity 2023: € 304,419 ▲ 7% vs 2022 (€ 285,090) Favourable step	€ 347,526 Equity 2024: € 347,526 ▲ 14% vs 2023 (€ 304,419) Favourable step	€ 347,526 Equity 2025: € 347,526 Unchanged (€ 347,526) Unchanged
Total debts	€ 153,957 Total debts 2022: € 153,957 First fiscal year in the series	€ 213,575 Total debts 2023: € 213,575 ▲ 39% vs 2022 (€ 153,957) Unfavourable step	€ 115,845 Total debts 2024: € 115,845 ▼ 46% vs 2023 (€ 213,575) Favourable step	€ 117,918 Total debts 2025: € 117,918 ▲ 2% vs 2024 (€ 115,845) Unfavourable step	▲ 2%
Cash	€ 145,402 Cash 2022: € 145,402 First fiscal year in the series	€ 137,821 Cash 2023: € 137,821 ▼ 5% vs 2022 (€ 145,402) Unfavourable step	€ 161,911 Cash 2024: € 161,911 ▲ 17% vs 2023 (€ 137,821) Favourable step	€ 185,371 Cash 2025: € 185,371 ▲ 14% vs 2024 (€ 161,911) Favourable step	▲ 14%
Land & buildings	€ 47,748 Land & buildings 2022: € 47,748 First fiscal year in the series	€ 37,042 Land & buildings 2023: € 37,042 ▼ 22% vs 2022 (€ 47,748) Unchanged	€ 26,335 Land & buildings 2024: € 26,335 ▼ 29% vs 2023 (€ 37,042) Unchanged	€ 15,629 Land & buildings 2025: € 15,629 ▼ 41% vs 2024 (€ 26,335) Unchanged	▼ 41%
Retained profit	€ 266,490 Retained profit 2022: € 266,490 First fiscal year in the series	€ 285,819 Retained profit 2023: € 285,819 ▲ 7% vs 2022 (€ 266,490) Favourable step	€ 328,926 Retained profit 2024: € 328,926 ▲ 15% vs 2023 (€ 285,819) Favourable step	€ 328,926 Retained profit 2025: € 328,926 Unchanged (€ 328,926) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 25,000 Dividend 2023: € 25,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 25,000) Unchanged	€ 24,889 Dividend 2025: € 24,889 Unchanged (€ 0) Unchanged
Bank debt	€ 73,841 Bank debt 2022: € 73,841 First fiscal year in the series	€ 49,284 Bank debt 2023: € 49,284 ▼ 33% vs 2022 (€ 73,841) Favourable step	€ 17,865 Bank debt 2024: € 17,865 ▼ 64% vs 2023 (€ 49,284) Favourable step	€ 3,674 Bank debt 2025: € 3,674 ▼ 79% vs 2024 (€ 17,865) Favourable step	▼ 79%
Balance sheet total	€ 439,048 Balance sheet total 2022: € 439,048 First fiscal year in the series	€ 517,995 Balance sheet total 2023: € 517,995 ▲ 18% vs 2022 (€ 439,048) Unchanged	€ 463,371 Balance sheet total 2024: € 463,371 ▼ 11% vs 2023 (€ 517,995) Unchanged	€ 465,443 Balance sheet total 2025: € 465,443 Unchanged (€ 463,371) Unchanged
Employees (FTE)	-	0.1 Employees (FTE) 2023: 0.1 First fiscal year in the series	0.2 Employees (FTE) 2024: 0.2 ▲ 0.1 vs 2023 (0.1) Unchanged	0.3 Employees (FTE) 2025: 0.3 ▲ 0.1 vs 2024 (0.2) Unchanged	▲ 0.1

Key figures of Apotheek Ellen Cogge, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Apotheek Ellen Cogge?

What happened at Apotheek Ellen Cogge in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 24,889 (▼ 42% vs 2024). Source: NBB ↗
Apr 24, 2007 New establishment in Gent. KBO
Mar 28, 2007 Start of the company according to the CBE. KBO

In short

From € 60,925 profit in 2022 to € 24,889 profit in 2025.

Paid € 59,606 in corporate taxes since 2022.

Best year ever: 2022, with € 60,925 profit.

Paid out € 49,889 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Copharelle 100%

The stake of Copharelle comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Ellen Cogge

Behind Apotheek Ellen Cogge is Copharelle BV. The shares are held by Copharelle (100%).

Directors

According to the 2025 annual accounts

Copharelle BV

Director · represented by Ellen Cogge

Shareholders

Copharelle

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heerweg-Zuid 135

9052 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Copharelle same network

€ 47,057 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0888.332.136

VAT number

BE 0888.332.136

Registered office

Heerweg-Zuid 135, 9052 Gent

Names & denominations

Apotheek Ellen Cogge

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 March 2007

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Ellen Cogge

Financials

What happened to Apotheek Ellen Cogge?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions